ADDEX PHARMACEUTICALS LTD. ORDINARY SHAR (OTCMKTS:ADDXF) Sellers Rose Their Shorts By 21.08% As Of Apr 17, 2018

April 17, 2018 - By Robert Reynolds

Addex Therapeutics Ltd (OTCMKTS:ADDXF) Corporate Logo

ADDEX PHARMACEUTICALS LTD. ORDINARY SHAR (OTCMKTS:ADDXF) had an increase of its shorted shares by 21.08%. FINRA published shorted shares of ADDXF’s total 42,500 shares. Previously was reported up change of 21.08% from 35,100 shares. ADDEX PHARMACEUTICALS LTD. ORDINARY SHAR (OTCMKTS:ADDXF) has 500 shares average volume. It’ll cost 85 days for ADDXF to restore its previous position. ADDEX PHARMACEUTICALS LTD. ORDINARY SHAR’s shorted shares float is 0.4%.

$3.3031 was the last price.Since April 17, 2017 it’s 0.00% down thus . ADDXF underperformed by 11.55% the S&P500.

Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for the treatment of human health.The firm is worth $46.05 million. The Company’s lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia and dystonia; ADX71149 for epilepsy and an undisclosed central nervous system disorders; ADX71441 for the treatment of Charcot-Marie-Tooth type 1A neuropathy; and ADX71441 for the treatments of addiction.Currently it has negative earnings. The firm focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: